Patent classifications
C03C17/30
Urea-functionalized sol-gel
Urea and amine comprising sol-gel hybrid coatings have been developed for numerous applications, including capillary microextraction-high performance liquid chromatographic analysis from aqueous samples. A fused silica capillary may be coated from the inside with surface bonded coating material and may be created by in-situ sol-gel reaction(s). Urea-functionalized coatings can be immobilized on the inner surface of a capillary by condensing silanol groups of capillary and sol-solution. Urea functionalized, sol-gel coated capillaries may be installed, e.g., in HPLC manual injection ports, and optionally pre-concentrated analytes including phenols, ketones, aldehydes, and/or polyaromatic hydrocarbons, from highly polar to non-polar, maybe analyzed by online extraction and high-performance liquid chromatographic. Such coatings may achieve sensitivities with lower detection limits (S/N=3) of 0.10 ng/mL to 14.29 ng/mL, with reproducibilities of <12.0% RSD (n=3), or <10.0% RSD (n=3) by exchanging the capillary of the same size.
Articles and methods for bonding sheets with carriers
Described herein are organosilicon modification layers and associated deposition methods and inert gas treatments that may be applied on a sheet, a carrier, or both, to control van der Waals, hydrogen and covalent bonding between a sheet and carrier. The modification layers bond the sheet and carrier together such that a permanent bond is prevented at high temperature processing as well as maintaining a sufficient bond to prevent delamination during high temperature processing.
Articles and methods for bonding sheets with carriers
Described herein are organosilicon modification layers and associated deposition methods and inert gas treatments that may be applied on a sheet, a carrier, or both, to control van der Waals, hydrogen and covalent bonding between a sheet and carrier. The modification layers bond the sheet and carrier together such that a permanent bond is prevented at high temperature processing as well as maintaining a sufficient bond to prevent delamination during high temperature processing.
REINFORCING MATERIAL AND RESIN MOLDED ARTICLE
A reinforcing material is disclosed that includes coated glass flakes and coated glass strands. When the total amount of a glycidyl group-including resin and aminosilane contained in the coatings of the coated glass flakes corresponds to 100% by mass, the amount of the resin is 30% to 95% by mass. When the total amount of a glycidyl group-including resin, aminosilane, and a urethane resin contained in the coatings of the coated glass strands corresponds to 100% by mass, the amount of the glycidyl group-including resin is 10% to 90% by mass, the amount of the aminosilane is 0.1% to 40% by mass, and the amount of the urethane resin is 1% to 50% by mass. Both the coated glass flakes and the coated glass strands have an ignition loss of 0.1% to 2.0% by mass measured pursuant to JIS R3420 (2013).
HARD COATING COMPOSITION, METHOD OF PRODUCING THE HARD COATING COMPOSITION, AND WINDOW INCLUDING HARD COATING LAYER
A hard coating composition includes a silica-silsesquioxane-based resin, a photoinitiator, and a diluting monomer. The diluting monomer includes at least one of a 2-hydroxyethyl acrylate monomer, a tetrahydrofurfuryl acrylic acid monomer, an isobornyl acrylate monomer, a cyclic trimethylolpropane formal acrylate monomer, and an acryloylmorpholine monomer.
HARD COATING COMPOSITION, METHOD OF PRODUCING THE HARD COATING COMPOSITION, AND WINDOW INCLUDING HARD COATING LAYER
A hard coating composition includes a silica-silsesquioxane-based resin, a photoinitiator, and a diluting monomer. The diluting monomer includes at least one of a 2-hydroxyethyl acrylate monomer, a tetrahydrofurfuryl acrylic acid monomer, an isobornyl acrylate monomer, a cyclic trimethylolpropane formal acrylate monomer, and an acryloylmorpholine monomer.
PHARMACEUTICAL CONTAINER, METHOD FOR MANUFACTURING PHARMACEUTICAL CONTAINER, AND COATING AGENT
A pharmaceutical container of the present invention is a pharmaceutical container including at least a container and a coating layer, and is characterized that the coating layer is coated on at least an inner surface of the container and the coating layer contains a silicone-based resin.
PHARMACEUTICAL CONTAINER, METHOD FOR MANUFACTURING PHARMACEUTICAL CONTAINER, AND COATING AGENT
A pharmaceutical container of the present invention is a pharmaceutical container including at least a container and a coating layer, and is characterized that the coating layer is coated on at least an inner surface of the container and the coating layer contains a silicone-based resin.
Process for obtaining a textured glass substrate coated with an antireflective coating of sol-gel type
A process for obtaining a material including a textured glass substrate coated, on at least one of its textured faces, with an antireflective coating of sol-gel type based on porous silica, includes a stage of application, to the at least one textured face of the substrate, of a solution containing at least one silica precursor and at least one pore-forming agent, then a heat treatment stage targeted at consolidating the antireflective coating. Before the application stage, the glass substrate is subjected to a preheating stage, so that the at least one textured face intended to be coated with the antireflective coating has a temperature within a range extending from 30° C. to 100° C. immediately before the application stage.
Antireflective member and method of manufacture therefor
Provided is an antireflective member that has a water- and oil-repellent layer on a multi-layered antireflective layer and is capable of exhibiting excellent surface lubricity, water- and oil-repellent properties, and durability. The surface of the multi-layered antireflective layer on a base material has a root-mean-square surface roughness of 0.8 nm to 2.0 nm. The water- and oil-repellent layer has a thickness of 1 to 30 nm and is a cured product of water- and oil-repellents having as principal components a fluorooxyalkylene group-containing polymer modified organosilicon compound with the numerical average molecular weight of 4,500 to 10,000 of a fluoropolymer part and/or partial hydrolysis condensate thereof.